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Abstract
Protein secretion is almost universally employed by bacteria. Some proteins are retained on the
cell surface, whereas others are released into the extracellular milieu, often playing a key role in
virulence. In this review, we discuss the diverse types and potential functions of post-translational
modifications (PTMs) occurring to extracellular bacterial proteins.
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Introduction
Until relatively recently, the nature and effects of post-translational modifications
(PTMs) were principally thought to be restricted to eukaryotic systems. However,
PTM in prokaryotes is now appreciated to be just as important and diverse as it is
in eukaryotes.1 The ever-expanding catalogue of bacterial PTMs ranges from
methylation and phosphorylation of residues to the addition of complex moieties
including lipids and glycans (Figure 1).1 These modifications can have profound
effects on proteins, altering their conformation, activity, stability and localisation,
as well as interactions with other molecules.2 The specific purpose of PTMs is not
always clear, although they have been shown to modulate and mediate key biologi-
cal processes, including central metabolism, signal transduction and virulence.3,4
Not surprisingly, many reversible PTMs also appear to be involved in mediating
rapid responses to environmental stimuli.5
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Historically, the earliest studies focused on the PTMs associated with individual
proteins, and often just on the impact of modifications at specific sites. However,
advances in proteomic technologies have driven a surge in the number of large-
scale global modification studies for a wide range of bacterial species.5,6 Despite
this, there are a number of clear limitations to the technology. High levels of purity
and quantity of protein are generally necessary for sufficient sequence coverage
and resolution to identify PTMs using mass spectrometry-based approaches.7 This
can be bolstered through selective enrichment of post-translationally modified pro-
teins (e.g. using antibody-based approaches) prior to mass spectrometric analysis,
although this is predicated on a high degree of specificity and high binding capacity
of the antibodies employed.8 Perhaps a more pervasive issue is that the greater the
number of different types of PTM to be identified, the larger the bioinformatic
search space required. This is due to an iterative search mechanism which attempts
to identify the presence or absence of each PTM on every modifiable residue. This
ultimately increases the rate of false discoveries.9 There are also limits on the mass
shift window authorised for searches, so larger modifications such as glycosylation
are frequently excluded.5 Consequently, independent approaches are often required
to validate these ‘‘high throughput’’ technologies.2,10 These include structural and
functional studies, although as always, these too can be challenging.11
Although it is now widely accepted that PTMs occur in bacteria, most studies
have focused on cell-associated protein modifications, and relatively few have con-
sidered the modifications associated with proteins secreted into the extracellular
milieu. Indeed, most culture supernatants are usually removed prior to mass spec-
trometric analysis.6,12–14 However, recent work has revealed a wealth of unexpected
Figure 1. An overview of the most common post-translational modifications in bacteria,
showing the amino acid side chains which are most frequently modified. PTMs are grouped by
colour according to their type; small chemical (blue), complex molecule (orange), protein
cleavage (red) and amino acid side chain modifications (green).
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PTMs associated with extracellular bacterial proteins, including phosphorylation,
methylation, acetylation, proteolytic processing, glycosylation and lipidation.15 In
this review, we assess the diversity and likely function(s) of PTMs associated with
extracellular bacterial proteins.
Phosphorylation
Protein phosphorylation is a ubiquitous and abundant PTM, usually associated
with intracellular signal transduction.16,17 The attachment and removal of phos-
phoryl groups on amino acid side chains is catalysed by kinases and phosphatases,
respectively.2 Serine, threonine and tyrosine are commonly phosphorylated in eukar-
yotes, whereas histidine and aspartate phosphorylation are thought to be more pre-
valent in prokaryotes, although this is disputed.18,19 Microbial phosphoanhydrides
(Asp-P) and phosphoramidates (His-P) are more labile than the phosphoesters that
form with Ser, Thr and Tyr side chains, and this makes them more difficult to
detect, especially if samples are exposed to acidic conditions during preparation.
Mycobacterium tuberculosis (Mtb) is a global health burden. The organism is
now strongly resurgent, partly due to widespread multi-drug resistance. Effector
proteins are secreted directly from the donor Mtb cell cytoplasm to the recipient
(host) cell cytoplasm through the multiprotein ESX-1 Type VII secretion system
(T7SS). Not only are a sizeable number of these structural proteins phosphorylated;
so too are some of the virulence factors which pass through this translocon, such as
the immune-triggering proteins EsxB and PtpA.18 PtpA is a tyrosine phosphatase
that is secreted into macrophages following phagocytosis of the bacterium, causing
inhibition of phagosome maturation and thus promoting bacterial survival. PtpA is
phosphorylated at several S/T/Y residues, and this has been shown to control its
activity and secretion.20 Interestingly, phosphorylation of multiple virulence factors
is up-regulated in the hypervirulent Mtb Beijing isolate.18 Phosphorylation is also
used as a regulatory mechanism to temporally control different stages of infection
by other bacterial species. The Helicobacter pylori cytotoxin CagA is phosphory-
lated on tyrosine by host membrane-associated Abl1 and/or Src family kinases.
Interestingly, CagA phosphorylation is stimulated by another H. pylori secreted
product, vacuolating toxin (VacA). This effector is itself phosphorylated but also
promotes the Src-mediated phosphorylation of CagA.21,22 CagA and VacA effec-
tors are involved in the early stages of gastric colonisation and are modified follow-
ing injection into the epithelial cells lining the stomach.23
Not all secreted effector proteins are phosphorylated by bacterial kinases. For
example, host kinases can phosphorylate some of the effector proteins produced
by enteropathogenic Escherichia coli and Citrobacter rhodentium.24 At least 4 pro-
teins secreted by the T2SS and T3SS of Chlamydial species are similarly modified,
including TarP and TeP, which facilitate entry into the mucosal epithelia.25
Bacteria can also hijack and control host systems through PTM. The Dot/Icm
(T4SS) of Legionella pneumophila translocates over 300 effectors, including a
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kinase, LegK, which can phosphorylate host proteins to interfere with normal cell
functioning.26
Elastase (LasB) secreted by Pseudomonas aeruginosa has also been shown to be
phosphorylated; indeed, 19 phospho-residues have been identified in the secreted
form, whereas only non-phosphorylated LasB appears intracellularly.27 The biolo-
gical role(s) of this phosphorylation have not been elucidated, although it is possi-
ble that the modification targets the enzyme for secretion. Indeed, some 28
phospho-exoproteins with a wide range of functions and degree of modification
were identified in one study of strain PA14. This suggests that there may be numer-
ous roles for phosphorylation, particularly in P. aeruginosa virulence.28
Surface-exposed bacterial proteins are also modified in many organisms. For
example, flagella proteins from several P. aeruginosa strains are S/T/Y phosphory-
lated and this modification often occurs at a very specific growth stage.29
Surprisingly, one of the main growth phase-dependent flagella PTMs (phosphory-
lation of the FliC N-terminus) does not affect swimming motility, but instead
increases Type II Secretion System (T2SS) activity whilst concomitantly decreasing
biofilm formation.30 Similarly, phosphorylation of the Neisseria gonorrhoeae type
IV pilus protein, PilE, at Ser68 also has little apparent effect on the motility-related
function of the protein, although it does influence the morphology of the pilus,
and consequently, antigenic variation.31 Outer membrane proteins (OMPs) from
Klebsiella pneumoniae, H. pylori and Shigella flexneri are also multi-phosphory-
lated, although the function of these PTMs remains unclear.32,33
Methylation
Methylation is well characterised in eukaryotes, notably the methylation of histones
to control gene transcription,34 but not well studied in bacteria. It involves the addi-
tion of up to two or three methyl groups to the side chain or terminal amine of argi-
nine or lysine, respectively. Glutamine and glutamic acid residues are also modified,
but to a lesser extent.1 S-adenosyl methionine (SAM) acts as a methyl donor, work-
ing in concert with methyltransferase enzymes to catalyse these reactions.
The P. aeruginosa secreted virulence factors CbpD (chitin binding protein) and
elastase are methylated at several lysine residues. However, these lysines are methy-
lated to different degrees, with mono-, di- and tri-methylated forms of the same
lysine present. This indicates that methylation can be highly variable, even for the
same protein.27 Variations in side chain methylation are also seen in the Gram-posi-
tive organism Clostridium thermocellum. This bacterium degrades cellulose by
secreting a complex of different proteins, known as the cellulosome. CipA, a cellu-
losome structural protein, is methylated at Glu1267 and trimethylated at Lys80 and
Lys663, although the protein is also secreted in an unmodified form. Contrastingly,
the cellulolytic CelK enzyme is consistently di-methylated at Lys652 under different
experimental conditions, suggesting that certain residue modifications are invari-
able. This PTM is postulated to promote protein flexibility, whereas methylation of
glutamic acid may aid cellulosome localisation.10
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Studies closely scrutinising secreted protein methylation are limited. However,
outer membrane proteins have been studied in greater detail. OMP 32 of
Leptospira interrogans undergoes extensive but irregular methylation. Eleven gluta-
mic acid residues are variably modified in response to mammalian host signals.35,36
This leads to OMP phase variation and reduced recognition by the host immune
system. Lysine methylation also alters the antigenicity of Rickettsia OMPs.37 Two
different lysine methyltransferases modify OmpB from Rickettsia prowazekii, with
one enzyme specifically catalysing tri-methylation at consensus sequences.38,39
Interestingly, the overall number of methylated lysine residues correlates with viru-
lence in this strain.
One of the earliest observations of methylation as a PTM occurred in 1959 dur-
ing an investigation of flagella structure and function.40 Over half a century later,
investigations have now revealed methylation of flagella proteins in a range of spe-
cies.41,42 Flagellin methylation by FliB, a component of the Salmonella enterica ser-
ovar Typhimurium flagella machinery, is necessary for swarming motility and
virulence43–45 and orthologous methyltransferases produced by other members of
the Enterobacteriaceae are encoded in flagellin methylase island loci (FMIs).42 In
addition to flagella, surface-associated pili can also be methylated. The pre-pilin
peptidase (PilD) of P. aeruginosa acts as a dual modifier, by cleaving the signal
peptide and then methylating the N-terminal phenylalanine of mature Type 4 pilus
subunits. Methylation happens prior to pilus assembly and is dependent on the
binding of zinc as a cofactor.46 This processing also occurs in Neisseria meningiti-
dis, although methylation is not a prerequisite for proper pilus assembly and the
true function of this PTM remains unknown.47,48
EF-Tu is an elongation factor that delivers charged tRNA to ribosomes in the
cytoplasm. It is also transported to the bacterial surface where it ‘‘moonlights’’ as
an environmental sensor and aids adherence to epithelial cells in many species.49 A
protein is described to ‘‘moonlight’’ when it has additional function(s) that are not
relevant to its primary role within the cell. P. aeruginosa EftM exclusively tri-
methylates EF-Tu on Lys5. This modification does not impact the canonical func-
tion of the protein in translation, but does mediate bacterial attachment to the
respiratory epithelia by mimicking phosphorylcholine (a component of the platelet
activating factor).50,51 Methylation is a prerequisite for infection, and deletion of
eftM decreases P. aeruginosa pathogenicity. Interestingly, EftM is thermoregu-
lated, displaying increased stability at 25C. This may suggest that methylation is
critical in the early stages of infection or for survival in non-host environments.50
This enzyme is well-conserved throughout the Pseudomonas and Vibrio genera and
methylation of EF-Tu has proven indispensable for many pathogens.51,52
Acetylation and succinylation
Acetylation predominantly occurs on the e-amine of lysine side chains (Ne-acetyla-
tion) and at N-terminal amino acids (Na-acetylation) in a co- or post-translational
fashion.1,53 This type of acylation can also occur on the side chains of serine,
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threonine and tyrosine (O-acetylation).2 Acetylation can occur enzymatically via
acetyltransferases (with acetyl groups also removed via the action of deacetylases)
or non-enzymatically. Both pathways require an acetyl donor, commonly acetyl-
CoA or acetyl-phosphate.1,54
Despite being proven to impact upon virulence in several species, the biological
significance of acetylation of extracellular proteins is not well defined.28,55–57
Acetylation of extracellular bacterial proteins increases as cultures approach and
enter the stationary phase of growth. This indicates that acetylation may impact
upon protein stability, perhaps circumventing the unnecessary use of scarce
resources to replenish vital proteins.5 The protein acetyltransferase (Pat) and dea-
cetylase (CobB) of S. enterica serovar Typhimurium are involved in cell survival
during growth following acidic stress, invasion of the host and replication within
macrophages. S. enterica serovar Typhimurium mutants that are unable to acety-
late proteins show reduced host inflammation, although how this relates to specific
virulence factors is currently unclear.58
In a study of the P. aeruginosa strain PA14 intracellular lysine acetylome, 522
modified proteins were identified. Additionally, acetylation was enhanced when
citrate was used as the sole carbon source.59 Notably, in addition to identifying
many acetylated intracellular proteins, several P. aeruginosa virulence factors (some
previously identified as methylated, such as CbpD and LasB) were also acetylated,
including protease IV, haemolysin, exotoxin A and several components of the
T6SS.27,57,59
Proteins involved in central metabolism are the main targets of acetylation in
Mtb. For example, malate synthase G (GlcB) is a component of the glyoxylate
shunt. However, GlcB is also secreted in an acetylated form to the surface of the
cell, enhancing bacterial adherence to the lung epithelium. Indeed, a further 45
secreted acetylated proteins from Mtb have been identified. Multi-acetylation of
heat shock protein X (HspX) inhibits the host immune response and has been
linked to the latency of Mtb infections.60 ESAT-6 (6 kDa Early Secreted Antigenic
Target) is inconsistently acetylated at the N-terminus, preventing protein-protein
interactions with its cognate chaperone CFP-10.61 ESAT-6 is able function alone
or in complex with CFP-10 to modulate the host immune response, and therefore
the purpose of acetylation-driven segregation of these proteins is unclear.62 Other
members of the ESAT-6 family also undergo Na-acetylation, including EsxN,
EsxO, EsxI and EsxA.63–65 Dephosphorylation of host proteins by PtbB is also
critical for Mtb infection. The phosphatase activity of PtbB is controlled by acety-
lation/succinylation of Lys224, which is found in the lid region that covers the
active site. This PTM therefore serves as a negative regulator of enzyme activity.65
Succinylation is another form of acylation alongside acetylation, malonylation,
propionylation, butyrylation and crotonylation. Although the identification of suc-
cinylated proteins is a relatively recent area of research, the overlap between acety-
lation and succinylation in the secretome of PA14 is significant,66 with around
41% of succinylation sites also susceptible to acetylation.59 The functional signifi-
cance of succinylation remains unclear, although the presence of succinyllysine
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within the pro-peptide of LasB indicates a potential role of this PTM in protein
maturation or stability. Moreover, the number of acetylated/succinylated lysine
residues in LasB increases upon secretion.27 Global profiling of succinylated pro-
teins in PA14 identified seven sequence motifs that may direct modification, with
the same signatures also evident in Vibrio parahaemolyticus and Mtb.59,66,67 This
suggests that succinylation of secreted proteins may be a more widespread PTM
than previously thought.
Proteolysis
Proteolytic cleavage of proteins is a common and irreversible PTM. Endoproteases
cleave the polypeptide chain at specific residues within sequence motifs, whereas
exoproteases cleave the N- and C- termini.
Many extracytoplasmic proteins are transported across the cytoplasmic mem-
brane (CM) through the sec translocation machinery, guided by an N-terminal sig-
nal peptide.68 In Gram-negative bacteria, additional secretion systems are
employed to further transport proteins from the periplasm to outside of the cell.69
Inhibition of the type 1 signal peptidases that cleave signal peptides results in the
accumulation of unprocessed proteins in the cytoplasm and ultimately, cell
death.70,71 Hidden Markov models can accurately predict signal peptide sequences,
although different algorithms are necessary for Gram-positive and Gram-negative
bacteria.72 AXA motifs are common at the N-terminal cleavage site,2,73 but this
can vary greatly between species.74 Somewhat controversially, in a study of Mtb
secreted proteins, only 16% of secreted proteins had a cleaved signal peptide; this
has also been seen in Bacillus subtilis.72,75 To our knowledge, the reason(s) for
these observed discrepancies in the cleavage of signal peptides have not been
investigated.
The substrates of the Por (type 9 secretion system, T9SS) of periodontitis-
associated Porphyromonas gingivalis contain conserved C-terminal domains (CTD)
that are essential for secretion. The principal virulence factors translocated through
the T9SS are cysteine protease gingipains.76 Cleavage of the gingipain CTDs by
PorU and PorZ following protein folding allows secretion through the outer mem-
brane (OM) and subsequent glycosylation.77–80 Current data implicate the tertiary
structure of the CTD as being the key signal for secretion,80,81 although some con-
served sequence motifs have also been identified.82 Bordetella filamentous haemag-
glutinin (FHA) also harbours a cleavable CTD. FHA is retained on the cell surface
via anchoring of the CTD within the FhaC transporter.83 Cleavage of the CTD
releases FHA from the surface, allowing passage of full-length unprocessed FHA
through FhaC to act as a transmembrane sensor.84 This intriguing interplay
between the two forms of FHA is tightly-regulated, ensuring successful colonisa-
tion and maintenance of infection.
An elegant cleavage cascade which activates several virulence factors has been
highlighted in P. aeruginosa (Figure 2). Elastase is synthesised as a pre-pro-protein
(53 kDa) which is cleaved and transported through the CM and OM by targeting
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and sequential cleavage of the pre- and pro-domains, respectively. The pro-domain
undergoes autoproteolytic cleavage post-folding in the periplasm but remains non-
covalently linked to the mature protein (33 kDa) where it inhibits intracellular pro-
tease activity.85 Both domains are then secreted through the Xcp T2SS machinery
and the pro-domain is subsequently degraded. A similar secretion pathway can be
seen in the production of subtilisin by Bacillus subtilis.86 Extracellular LasB pro-
cesses CbpD at the N-terminus, yielding LasD, which in turn, cleaves LasA into its
mature staphylolytic form.85,87,88 The processing of these enzymes works as a posi-
tive feed-forward mechanism because LasA further enhances the elastolytic activity
of LasB.27,85 LasB also activates leucine aminopeptidase by cleaving the C-terminal
pro-sequence, which contains an active site-inhibitory lysine residue. Substitution
of this C-terminal lysine with an acidic alternative results in leucine aminopeptidase
activation without the need for LasB processing.89
Some cleavage events produce multiple functional products. For example, auto-
lysin synthesised by Staphylococcus aureus is cleaved at four locations to produce
functionally distinct extracellular hydrolases, an amidase and a glucosaminidase.68
In several diverse pathogens, EF-Tu is also cleaved into fragments which are then
expressed on the cell surface. Here they act as adherence factors, binding a range of
host substrates and mediating colonisation of different niches.52
Figure 2. Pseudomonas aeruginosa LasB secretion pathway and subsequent proteolytic cleavage
cascade. The pre-pro-protein is targeted to the periplasm through the sec translocon via the
encoded signal peptide. The protein is then folded, and the pro-domain is cleaved, remaining
non-covalently bound to the mature protein. Following secretion via the T2SS Xcp machinery,
the pro-domain is degraded and a cleavage cascade begins. Mature LasB cleaves CbpD into LasD,
which then activates LasA by proteolysis. Mature LasA enhances the elastolytic activity of LasB.
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Glycosylation
Glycosylation involves the covalent attachment of a carbohydrate to the amide
group of asparagine (N-linked) or the hydroxyl group of serine or threonine (O-
linked).90–95 Attachment of glycans is a multi-step process involving different
enzymes,96 which are commonly encoded within gene clusters with their sub-
strates.42 Promiscuous glucosyltransferases generate extensive variability in the gly-
cosyl moieties of modified proteins.97,98 Two main glycosylation pathways are
used in bacteria, either via the en bloc transfer of glycan chains (preassembled on
lipid carriers) to proteins, or sequential attachment from nucleotide-activated
sugars.99
There are few examples of bacterial glycoproteins which are fully secreted into
the extracellular milieu; most such modified proteins remain attached to the
cell.100–102 The best-studied glycoproteins are flagellins.41,103–105 Campylobacter
jejuni flagella are N-glycosylated by PglB with a nine-carbon pseudaminic acid,
which transfers glycan moieties en bloc to proteins at the sequon D/E-X-N-X-S/T
(X 6¼ Pro),106,107 although some exceptions to this rule have been found.108
Functionally, glycosylation may have multiple roles. For example, adherence of
Clostridium difficile in the human gut is dependent on N-acetyl-glucosamine glyco-
sylation of flagellar proteins. This glycan-induced switch to a more sessile mode
aids biofilm formation.109 Flagellar glycosylation may also play a protective role.
For example, the flagella of Burkholderia cepacia are modified at .10 sites, and
these modifications are required for auto-agglutination, resistance to acid, and
blocking of toll-like receptor 5 recognition.110–112
Many Pseudomonads encode a genomic glycosylation island as part of the fla-
gella regulon.98,103 P. aeruginosa produces two types of flagellin proteins which are
distinguished by their antigenicity. Both types are glycosylated, although they are
modified by different machinery encoded by different gene clusters. O-linked glyco-
sylation occurs at Thr189 and Ser260 found in the central surface-exposed domain
of each A type flagellin unit.98 Interestingly, type B flagellins are also glycosy-
lated twice, at Ser191 and Ser195.103 Whilst the specific role of O-linked
flagella glycosylation is unclear in P. aeruginosa, glycosylation of flagella in
Pseudomonas syringae is involved in bacterial recognition by plants, and can
shape host specificity.113
O-glycosylation is commonly used to protect surface-associated proteins
from degradation by extracellular proteases. H. pylori alpha and beta ureases,
Microcystis aeruginosa microcystin-related protein C, and Streptococcus
mutans binding protein Cnm all undergo O-glycosylation to increase protein
stability.97,114,115 This is also the case for EmaA, the only Aggregatibacter acti-
nomycetemcomitans autotransporter adhesin which is currently known to be
glycosylated. The other adhesins, ApiA and AaE, are unmodified.116
Additional autotransporter proteins and adhesins from unrelated bacteria are
also secreted as glycoproteins, including AtaC from Actinobacillus pleuropneu-
moniae, and the self-assembling TibA from E. coli.117,118 Glycosylation of
TibA by TibC enhances stability and adhesion to epithelial cells, although the
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modification is not known to affect invasion or aggregation of E. coli, unlike
its other autotransporter glycoproteins.117
Adherence-promoting surface fimbriae can also be modified by O-linked glyco-
sylation. For example, unmodified fimbria-associated glycoprotein (Fap1) from
Streptococcus parasanguinis mediates cell adhesion, whereas following glycosyla-
tion, the protein becomes essential for biofilm development.119 Variable glycosyla-
tion of Gram-negative pili is also widespread.48,99 Two of the five type 4 pili
produced by P. aeruginosa are modified by PilO via the addition of O-antigen or
polymers of D-arabinofuranose. The even distribution of glycans on the pili fibrils
confers protection against infection by bacteriophage which target pili as receptors
for adsorption.120 In true tit-for-tat competitive style however, phage can mutate
their tail proteins and adapt their specificity to re-sensitise against the bacterial
host.121 Overall glycosylation of surface proteins contributes towards enhanced
protection and stability; improved adherence, invasion and immune stimulation;
and increased uptake of DNA.107,122
Lipidation
Lipidation is another complex PTM, typically involving the addition of two or
three lipids to the N-terminal cysteine of lipobox sequence motifs.123,124 The lipid
moieties act as a surface anchor and tend to reflect the fatty acid composition of
membrane phospholipids. This contributes to the significant antigenic variability
of lipoproteins between- and within-species.125,126 The lipoprotein biosynthesis
pathway involves up to three sequential enzymatic reactions (Figure 3).127,128
Interestingly, and despite not encoding a homologue of the final N-acyltransferase
enzyme (Lnt), many low G+C Gram-positive organisms are still able to produce
triacylated lipoproteins.129–131
Lipoproteins play a substantial role in bacterial growth and pathogenicity. The
role(s) played by lipidation are nothing if not diverse. For example, lipidation
enhances Streptococcal adherence to endothelial cells, and loss of a single S. san-
guinis lipoprotein (the metal ion transporter, SsaB) drastically decreases the ability
of the organism to cause endocarditis.133–135 Lipidation is also known to affect the
flagellar-driven motility of C. jejuni in the gut136 and significantly impacts the viru-
lence of Enterococcus faecalis. Somewhat unexpectedly, loss of the lipidation
enzymes also enhances E. faecalis growth under stressed conditions.137 In contrast,
the growth of S. aureus during nutrient limitation has been reported to be depen-
dent on lipidation.138 Interestingly, S. aureus triacyl-lipoprotein production is
strongly-dependent on environmental parameters and growth phase, with diacyl
forms dominating in high-stress conditions.139 Indeed, the role of the third fatty
acid has been questioned in Gram-positive organisms as triacylation is generally
thought to target lipoproteins across the outer membrane.
N. meningitidis surface antigen Factor H binding protein (FHbp) is normally tri-
palmitoylated in vivo. In contrast to previous reports, deletion of Lnt (which adds
the third palmitoyl group) does not prevent the surface expression of diacylated
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FHbp.140,141 However, the outer membrane Lol transporter has a higher affinity
for the triacylated form and accumulation of diacylated FHbp results in negative
feedback and reduced overall FHbp synthesis. It is possible that production of both
the di- and tri-acylated FHbp isoforms may confer a fitness advantage in terms of
antigen recognition, or that sole production of the diacylated FHbp isoform leads
to a fitness disadvantage (e.g. via elevated antibiotic sensitivity due to increased
membrane permeability142).
Surface dissociation of di- or triacylated lipoproteins during infection activates
host TLR2/6 or TLR2/1 heterodimers respectively, which drives inflamma-
tion.132,143,144 In S. aureus, lipoprotein release is mediated by quorum sensing-
controlled expression of surfactant-like phenol-soluble modulins (PSMs). These
small peptides not only promote the release of lipoprotein-containing membrane
vesicles during cell turgor in hypotonic conditions, but themselves act as potent
virulence factors.145 Another virulence factor that is regulated by lipidation is the
secreted pore-forming toxin, haemolysin, from E. coli. This toxin induces apoptosis
in target host cells and is activated prior to export by the addition of fatty acids to
two internal lysine residues.146,147 Many other species also use lipidation to regu-
late haemolysin activity e.g., palmitoylation of B. pertussis haemolysin.148,149
Figure 3. Biosynthesis pathway of lipoproteins in E. coli. Preprolipoproteins are synthesised
in the cytoplasm and targeted through the sec translocon to the periplasm via their N-terminal
signal peptide. Diacylglycerol transferase (Lgt) transfers diacylglycerol to the thiol group of the
last cysteine in the four-residue lipobox motif. After this, lipoprotein signal peptidase (Lsp)
cleaves the signal peptide immediately before the derivatised cysteine and apolipoprotein
N-acyltransferase (Lnt) transfers another acyl group to the cysteine Na moiety. The mature
lipoprotein is recognised by the Lol ABC transporter, which transfers the lipoprotein to the
outer membrane.132
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The localisation of virulence factors within host cells is important for their bio-
logical function. The HopZ family of T3SS effectors produced by P. syringae
are targeted to the plant host plasma membranes via myristoylation.150,151
Proper targeting of these effectors causes programmed cell death through immune
modulation.152 In a remarkable example of molecular subterfuge, some pathogens
encode a CAAX motif on their secreted proteins; this motif is lipidated by
host acyltransferases, thereby targeting the effectors to distinct organelles.
Palmitoylation by host cell enzymes is also essential for the proper localisation, sta-
bility and activity of the polyclonal B-cell mitogen, PrpA, produced by Brucella
species.153 Indeed, this may be a common feature of many intracellular pathogens,
since secreted proteins produced by L. pneumophila and S. enterica serovar
Typhimurium have also been shown to hijack the host cell machinery during tar-
geting, thereby presumably conserving costly resources.154–156
Concluding remarks
Since the start of the 21st century, considerable gains have been made in the field
of prokaryotic PTM research. However, until recently, the importance of extra-
cellular protein PTMs has been largely underestimated. Nonetheless, many
secreted proteins from diverse bacterial species have been shown to be modified
in a variety of ways. Although some of these modifications are proving essential
for bacterial physiology and virulence, the purpose of many others remains
unresolved. What is clear though, is that PTM is not a singular mechanism of
control, and global studies of bacterial proteomes have shown considerable
overlap between modifications.2,157 This notwithstanding, the era of defining the
type and extent of such PTMs now seems to be drawing to a close; the challenge
for the future generation will be in defining the biology underpinning these
modifications.
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